![](/images/graphics-bg.png)
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines
Joint Authors
Goyvaerts, Cleo
Breckpot, Karine
Source
Journal of Immunology Research
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-18, 18 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-10-25
Country of Publication
Egypt
No. of Pages
18
Main Subjects
Abstract EN
In therapeutic antitumor vaccination, dendritic cells play the leading role since they decide if, how, when, and where a potent antitumor immune response will take place.
Since the disentanglement of the complexity and merit of different antigen-presenting cell subtypes, antitumor immunotherapeutic research started to investigate the potential benefit of targeting these subtypes in situ.
This review will discuss which antigen-presenting cell subtypes are at play and how they have been targeted and finally question the true meaning of targeting antitumor-based vaccines.
American Psychological Association (APA)
Goyvaerts, Cleo& Breckpot, Karine. 2015. Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines. Journal of Immunology Research،Vol. 2015, no. 2015, pp.1-18.
https://search.emarefa.net/detail/BIM-1068594
Modern Language Association (MLA)
Goyvaerts, Cleo& Breckpot, Karine. Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines. Journal of Immunology Research No. 2015 (2015), pp.1-18.
https://search.emarefa.net/detail/BIM-1068594
American Medical Association (AMA)
Goyvaerts, Cleo& Breckpot, Karine. Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines. Journal of Immunology Research. 2015. Vol. 2015, no. 2015, pp.1-18.
https://search.emarefa.net/detail/BIM-1068594
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1068594